FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39198511000001106: Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
153981000001118 Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
153991000001116 Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Is a Tezacaftor 50mg / Ivacaftor 75mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has AMP Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Tezacaftor true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Symkevi 50mg/75mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start